Get started
Author

Rolf Kramer

Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
2024 · Sonia Ares-Gómez, Narmeen Mallah, et al. · The Lancet Infectious Diseases · 289
Volatile sesquiterpenes from fungi: what are they good for?
2011 · Rolf Kramer, Wolf-Rainer Abraham · Phytochemistry Reviews · 203
PDF
Environmental drivers of viral community composition in Antarctic soils identified by viromics
2017 · Evelien M. Adriaenssens, Rolf Kramer, et al. · Microbiome · 159
PDF
Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements
2015 · Rolf Kramer, Annette Sauer-Heilborn, et al. · Journal of Clinical Microbiology · 86
PDF
Extensively drug-resistant Klebsiella pneumoniae ST307 outbreak, north-eastern Germany, June to October 2019
2019 · Sebastian Haller, Rolf Kramer, et al. · Eurosurveillance · 82
PDF
Molecular diversity and biennial circulation of enterovirus D68: a systematic screening study in Lyon, France, 2010 to 2016
2018 · Rolf Kramer, Marina Sabatier, et al. · Eurosurveillance · 76
PDF
Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men
2018 · Caroline Charre, Laurent Cotte, et al. · PLoS ONE · 67
PDF
Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France
2018 · Rolf Kramer, Antoine Duclos, et al. · Vaccine · 45
Burden of RSV infections among young children in primary care: a prospective cohort study in five European countries (2021–23)
2025 · Sarah F Hak, Valérie D V Sankatsing, et al. · The Lancet Respiratory Medicine · 40
A rapid method for breath analysis in cystic fibrosis patients
2014 · R. Kramer, A. Sauer-Heilborn, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 38
PDF
Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review
2024 · Susanne Heemskerk, Lotte van Heuvel, et al. · Influenza and Other Respiratory Viruses · 34
PDF
Underreporting and Misclassification of Respiratory Syncytial Virus–Coded Hospitalization Among Adults in Denmark Between 2015–2016 and 2017–2018
2023 · Amanda Marie Egeskov-Cavling, Caroline Klint Johannesen, et al. · The Journal of Infectious Diseases · 32
PDF
Rapid spread of OXA-244-producing Escherichia coli ST38 in Germany: insights from an integrated molecular surveillance approach; 2017 to January 2020
2020 · Katrin Kremer, Rolf Kramer, et al. · Eurosurveillance · 30
PDF
Impact of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis in Hospitalized Infants: A Real-World Study
2024 · Eric Jeziorski, Antoine Ouziel, et al. · The Pediatric Infectious Disease Journal · 29
High Individuality of Respiratory Bacterial Communities in a Large Cohort of Adult Cystic Fibrosis Patients under Continuous Antibiotic Treatment
2015 · Rolf Kramer, Annette Sauer-Heilborn, et al. · PLoS ONE · 29
PDF
Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–2022
2023 · Moritz Wick, Anahita Poshtiban, et al. · Influenza and Other Respiratory Viruses · 28
PDF
Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy
2023 · Sebastien Kenmoe, Helen Y Chu, et al. · The Journal of Infectious Diseases · 24
PDF
Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice
2019 · Rolf Kramer, Bruno Lina, et al. · European Journal of Paediatric Neurology · 22
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
2024 · Narmeen Mallah, Sonia Ares-Gómez, et al. · Human Vaccines & Immunotherapeutics · 20
Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis
2022 · Oliver Damm, Anya Krefft, et al. · Influenza and Other Respiratory Viruses · 20
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling study
2025 · Caroline Klint Johannesen, David Gideonse, et al. · The Lancet Regional Health - Europe · 19
Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis
2023 · Shuyu Deng, Ling Guo, et al. · The Journal of Infectious Diseases · 19
PDF
Epidemiology and economic burden of meningococcal disease in Germany: A systematic review
2022 · S. Gruhn, J. Witte, et al. · Vaccine · 19
PDF
Nirsevimab effectiveness on paediatric emergency visits for RSV bronchiolitis: a test-negative design study
2025 · Lea Lenglart, Corinne Levy, et al. · European Journal of Pediatrics · 17
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis
2025 · Xiao Li, Lander Willem, et al. · BMC Medicine · 16
Works count: 71
Citation count: 1,670
H-index: 20
I10-index: 36
Year
Topic
Type